Latham helps Allergan sell in biggest deal of 2014
Latham & Watkins LLP represented Irvine-based Botox maker Allergan Inc. in its proposed $66 billion sale to Actavis Plc, a deal announced Nov. 17. Actavis, based in Dublin, Ireland, is offering $219 per Allergan share.
Actavis will pay $129.22 in cash and 0.37 shares of Actavis stock for each Allergan share.
Partners Cary K. Hyden and M...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In